Fig. 1 · Structure
Documents & Downloads
Cenupatide
uPAR Inhibitor
Cenupatide is a selective uPAR inhibitor that targets the urokinase-type plasminogen activator receptor. This compound exhibits significant anti-angiogenic and anti-inflammatory properties, making it valuable in research related to cancer biology and inflammatory diseases. It serves as a useful tool for studying the role of uPAR in various pathological conditions and therapeutic interventions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1006388-38-0 |
| Applications | uPAR Inhibitor |
| Formula | C28H47N11O5 |
| Molecular Weight | 617.74 |
| SMILES | CC(=O)N[C@@H](CCCNC(N)=N)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@](C)(Cc1ccccc1)C(N)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.